Hong Kong · Delayed Price · Currency is HKD Wuhan YZY Biopharma Statistics
Total Valuation
HKG:2496 has a market cap or net worth of HKD 639.70 million. The enterprise value is 712.03 million.
| Market Cap | 639.70M |
| Enterprise Value | 712.03M |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2496 has 193.85 million shares outstanding.
| Current Share Class | 179.48M |
| Shares Outstanding | 193.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.52% |
| Owned by Institutions (%) | 8.61% |
| Float | 1.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.82 |
| PB Ratio | -9.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55
| Current Ratio | 0.55 |
| Quick Ratio | 0.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.51% |
| Return on Invested Capital (ROIC) | -12.95% |
| Return on Capital Employed (ROCE) | 37.04% |
| Weighted Average Cost of Capital (WACC) | 6.10% |
| Revenue Per Employee | 1.07M |
| Profits Per Employee | -545,964 |
| Employee Count | 68 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 11.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.07% in the last 52 weeks. The beta is 0.49, so HKG:2496's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -44.07% |
| 50-Day Moving Average | 3.62 |
| 200-Day Moving Average | 5.42 |
| Relative Strength Index (RSI) | 1.16 |
| Average Volume (20 Days) | 330 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2496 had revenue of HKD 72.52 million and -37.13 million in losses. Loss per share was -0.19.
| Revenue | 72.52M |
| Gross Profit | 32.70M |
| Operating Income | -25.04M |
| Pretax Income | -37.13M |
| Net Income | -37.13M |
| EBITDA | -20.86M |
| EBIT | -25.04M |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 87.74 million in cash and 160.06 million in debt, with a net cash position of -72.33 million or -0.37 per share.
| Cash & Cash Equivalents | 87.74M |
| Total Debt | 160.06M |
| Net Cash | -72.33M |
| Net Cash Per Share | -0.37 |
| Equity (Book Value) | -67.60M |
| Book Value Per Share | -0.35 |
| Working Capital | -121.21M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4.24M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 45.09%, with operating and profit margins of -34.53% and -51.20%.
| Gross Margin | 45.09% |
| Operating Margin | -34.53% |
| Pretax Margin | -51.20% |
| Profit Margin | -51.20% |
| EBITDA Margin | -28.77% |
| EBIT Margin | -34.53% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2496 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.80% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |